REFERENCE
[미국] Potentially candidate for therapeutic antibodies against canine parvovirus
Summary: The present invention is directed to Parvovirus monoclonal antibodies to reduce or eliminate the severity of morbidity and mortality associated with CPV.
The present invention is directed to Parvovirus monoclonal antibodies to prevent CPV infection.